Skip to content

Substance Abuse and Rehabilitation

ISSN 1179-8467

2 papers in the library · 239 citations · publishing 2011-2013

Papers

To use or not to use: an update on licit and illicit ketamine use

Substance Abuse and Rehabilitation March 1, 2011 Jih-Heng Li, Vickna Kasinather, Cheung et al. 146 citations

Ketamine, an anesthetic developed in the 1960s, has hallucinogenic effects and a wide safety margin, but its therapeutic use is limited by mind-body dissociation, delirium, and hallucinations. Increasing recreational abuse, including to experience a "k-hole," has led to government restrictions. Long-term use can cause irreversible urinary tract damage, potentially leading to renal failure and dialysis. Assessments suggest ketamine may cause more harm than some UN-scheduled drugs, with dependence, lower urinary tract dysfunction, and sexual impulse or violence reported in Southeast and East Asia. The danger of ketamine may have been underestimated, and thorough surveys are needed to prevent an epidemic. However, recent findings indicate ketamine may be useful for treating major depressive disorder, prompting need for further research on risks and benefits.

3,4-methylenedioxymethamphetamine (MDMA): current perspectives

Substance Abuse and Rehabilitation November 1, 2013 Jerry Meyer 93 citations

Ecstasy, a recreational drug usually containing MDMA, produces euphoria, arousal, enhanced mood, sociability, and heightened perceptions, but also adverse effects like nausea, headache, tachycardia, bruxism, and trismus. Mood lowering can occur 2 to 5 days after use. Acute effects stem from increased release and inhibited reuptake of serotonin and norepinephrine, plus possible oxytocin release. Repeated or high-dose use is linked to tolerance, depressive symptoms, and cognitive deficits, especially in memory. Animal studies show high doses reduce forebrain serotonin markers, suggesting neurotoxicity or long-term downregulation.